News | June 04, 2021
Lupin launches generic version of Brovana in US
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
Arformoterol Tartrate Inhalation Solution is for treatment of bronchoconstriction
These vaccine doses will be manufactured and stockpiled by the company from August-December 2021
7.94 crore doses were made available to the states in May 2021
MEK inhibitor compound (LNP3794) developed as part of its oncology pipeline had previously shown pre-clinical activity as a single agent as well as in combination
NATCO and Arrow shall launch the product on agreed-upon launch dates in the future.
We focused on developing the product last year but now our focus is on ramping up our manufacturing capacity
Number of approved manufacturing sites of Remdesivir in the country has increased from 22 sites to 60
A total quantum of more than 4.39 crore doses was also available for direct procurement by the states as well as private hospitals in the month of May 2021
Financial support is being provided as a grant from the Government of India
The company is working closely with its six manufacturing partners in India
Subscribe To Our Newsletter & Stay Updated
